Don't miss this interesting discussion on pressing issues in healthcare and what role patient advocates can plan towards a future devoid of health disparities.

Without access, patients cannot benefit from novel and innovative therapies such as cell and gene therapies.

The value of these therapies to patients is therefore limited to the extent to which they can be accessed.

A necessity for effective patient access is early patient involvement by directly involving patients and learning about their expectations and needs.

Bojana and Philipp will discuss how patient advocacy and patient engagement can help prepare patient access.

Our host, Roger Legtenberg, shares with you several extracts from a recent LinkedIn Live event which starred Tom Smith, an independent patient consultant at Above Disease Level, together with Andreas Reimann, co-founder and managing partner of admedicum, who shared their thoughts on the roles & best practices for patient involvement in HTA processes.

We welcomed Ana Mingorance, Scientific Advisor of the Loulou foundation and Phillipp von Gallwitz, a patient activist for CDKL5 and co-founder of admedicum who shared their views in a lively discussion about this exciting topic with our host Roger Legtenberg.